4//SEC Filing
Foresite Capital Fund IV, L.P. 4
Accession 0001209191-23-028527
CIK 0001797768other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:42 PM ET
Size
18.4 KB
Accession
0001209191-23-028527
Insider Transaction Report
Form 4
Foresite Capital Management IV, LLC
10% Owner
Transactions
- Purchase
Common Stock
2023-05-08$2.80/sh+1,550,956$4,342,677→ 3,525,957 total(indirect: See Footnote) - Purchase
Common Stock
2023-05-08$2.80/sh+229,044$641,323→ 520,711 total(indirect: See Footnote)
Holdings
- 9,671,643(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The shares are owned directly by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum ("Dr. Tananbaum") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- [F2]The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- [F3]The shares are owned directly by Foresite Capital Fund IV, L.P. ("Fund IV"). Foresite Capital Management IV, LLC ("FCM IV") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum, in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001704131
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:42 PM ET
- Size
- 18.4 KB